Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene plus docetaxel versus docetaxel alone for previously treated advanced non-small cell lung cancer
ChiCTR-TRC-10000976Phase 4Completed
- Sponsor
- Beijing Chest Hospital
- Start
- Jun 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in non-small cell lung cancer (NSCLC) comparing Elemene plus docetaxel with Docetaxel monotherapy (2 arms). Primary endpoints: progression-free survival and quality of life evaluation. Started Jun 2009; status: completed.
02
Drugs
Elemenedocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-10000976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000976.